These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29344890)

  • 1. Prediction of Clinical Endpoints in Breast Cancer Using NMR Metabolic Profiles.
    Euceda LR; Haukaas TH; Bathen TF; Giskeødegård GF
    Methods Mol Biol; 2018; 1711():167-189. PubMed ID: 29344890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Processing and modeling of nuclear magnetic resonance (NMR) metabolic profiles.
    Ebbels TM; Lindon JC; Coen M
    Methods Mol Biol; 2011; 708():365-88. PubMed ID: 21207301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Principal component directed partial least squares analysis for combining nuclear magnetic resonance and mass spectrometry data in metabolomics: application to the detection of breast cancer.
    Gu H; Pan Z; Xi B; Asiago V; Musselman B; Raftery D
    Anal Chim Acta; 2011 Feb; 686(1-2):57-63. PubMed ID: 21237308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic fingerprinting of Tussilago farfara L. using ¹H-NMR spectroscopy and multivariate data analysis.
    Zhi HJ; Qin XM; Sun HF; Zhang LZ; Guo XQ; Li ZY
    Phytochem Anal; 2012; 23(5):492-501. PubMed ID: 22371211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
    Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
    J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic fingerprinting in breast cancer stages through
    Suman S; Sharma RK; Kumar V; Sinha N; Shukla Y
    J Pharm Biomed Anal; 2018 Oct; 160():38-45. PubMed ID: 30059813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting long-term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling.
    Cao MD; Sitter B; Bathen TF; Bofin A; Lønning PE; Lundgren S; Gribbestad IS
    NMR Biomed; 2012 Feb; 25(2):369-78. PubMed ID: 21823183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast Cancer Metabolomics Using NMR.
    Sharma U; Jagannathan NR
    Methods Mol Biol; 2019; 2037():195-213. PubMed ID: 31463847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR-based serum metabolomics study reveals a innovative diagnostic model for missed abortion.
    Wu Z; Jin L; Zheng W; Zhang C; Zhang L; Chen Y; Guan J; Fei H
    Biochem Biophys Res Commun; 2018 Feb; 496(2):679-685. PubMed ID: 29353036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1H NMR Metabolomics Reveals Association of High Expression of Inositol 1, 4, 5 Trisphosphate Receptor and Metabolites in Breast Cancer Patients.
    Singh A; Sharma RK; Chagtoo M; Agarwal G; George N; Sinha N; Godbole MM
    PLoS One; 2017; 12(1):e0169330. PubMed ID: 28072864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR metabolomic analysis of exhaled breath condensate of asthmatic patients at two different temperatures.
    Motta A; Paris D; D'Amato M; Melck D; Calabrese C; Vitale C; Stanziola AA; Corso G; Sofia M; Maniscalco M
    J Proteome Res; 2014 Dec; 13(12):6107-20. PubMed ID: 25393672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactate and glycine-potential MR biomarkers of prognosis in estrogen receptor-positive breast cancers.
    Giskeødegård GF; Lundgren S; Sitter B; Fjøsne HE; Postma G; Buydens LM; Gribbestad IS; Bathen TF
    NMR Biomed; 2012 Nov; 25(11):1271-9. PubMed ID: 22407957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lemna minor L. as a model organism for ecotoxicological studies performing 1H NMR fingerprinting.
    Aliferis KA; Materzok S; Paziotou GN; Chrysayi-Tokousbalides M
    Chemosphere; 2009 Aug; 76(7):967-73. PubMed ID: 19443011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absolute quantification of metabolites in breast cancer cell extracts by quantitative 2D (1) H INADEQUATE NMR.
    Martineau E; Tea I; Akoka S; Giraudeau P
    NMR Biomed; 2012 Aug; 25(8):985-92. PubMed ID: 22331830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of metabolic profile of intact non-tumor and tumor breast cells by high-resolution magic angle spinning nuclear magnetic resonance spectroscopy.
    Maria RM; Altei WF; Andricopulo AD; Becceneri AB; Cominetti MR; Venâncio T; Colnago LA
    Anal Biochem; 2015 Nov; 488():14-8. PubMed ID: 26247715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in metabolomics in oncology.
    O'Connell TM
    Bioanalysis; 2012 Feb; 4(4):431-51. PubMed ID: 22394143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolite Profiling of Clinical Cancer Biofluid Samples by NMR Spectroscopy.
    Mickiewicz B; Hyndman ME; Vogel HJ
    Methods Mol Biol; 2019; 1928():251-274. PubMed ID: 30725460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the 1H-NMR plasma metabolome reflect the host-tumor interactions in human breast cancer?
    Richard V; Conotte R; Mayne D; Colet JM
    Oncotarget; 2017 Jul; 8(30):49915-49930. PubMed ID: 28611296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Chemometrics Approach for Nuclear Magnetic Resonance Data to Characterize the Partial Metabolome Banana Peels from Southern Brazil.
    Cardoso S; Maraschin M; Peruch LAM; Rocha M; Pereira A
    J Integr Bioinform; 2017 Dec; 14(4):. PubMed ID: 29236677
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.